This site is intended for health professionals only
Saturday 23 June 2018
Share |

SMC accepts six new medicines for routine use in NHS Scotland

Related articles

A report from the charity Cancer Research UK has called on the health service to prepare for a large increase in the number of over 75s with cancer
Global pharmaceutical company to discontinue a late-stage trial assessing the efficacy of an experimental therapy in reducing chronic cluster headaches.
Manufacturer Amgen has received approval from the European Commission (EC) to include overall survival (OS) data on the labels of the drug BLINCYTO (blinatumomab), it has announced.

The Scottish Medicines Consortium (SMC), which reviews newly licensed medicines, has published advice accepting six new medicines for routine use by NHS Scotland.

Ads by Google